THE DEVIL'S IN THE RECOVERY TRIAL, page-3

I don't know Semi.
Massive market, strong potential for other massive markets.
Device works, is safe (drivelines a bit of a concern?)," plug and play" with no unwanted side effects and its backed by hard evidence and science.
20% recovery rate in 9 to 12 months, benefits from day 1. (a 2% recovery would be considered massive)

Every other initiative has failed, devices, stem cells etc.

Play with SSH, or for the foreseeable future, don't play in HF at all.

I have no concern that we will get finance, the price is the problem.

Data and science has got the doctors onboard.
Marketing to patients is the problem.

Making RECOVERY the aim seems like a very good change.
Doctors are excited and challenged by it.
We have learnt how strong patient resistance is to having drive lines coming out of their body, especially when it is forever. They're not jumping at the benefits. Giving a time frame 9 to 12 mths after which the device is removed or continued at their discretion is a big plus.
Offers an opportunity to accelerate before fully implantable is available.

Still leaves the US trial a little orphaned although we have forty sites and strong clinician support.

If no ones interested? Cant really see this.
One party interested. Screwed but get finance.
2 parties interested. Finance better.
3 parties interested. Might get a decent price.


Again I don't think finance is the problem, I could be wrong, but the argument for it is strong, price a problem, still some years from pay day.s